Moneycontrol PRO

Lupin: Focus on inhalation and bio-similars to aid margins in medium term

In the medium term, the focus is likely to be on the inhalation and biosimilar categories for Lupin, with scale-up in both US and European markets

May 14, 2021 / 06:36 PM IST
Lupin: Focus on inhalation and bio-similars to aid margins in medium term

Themis Medicare | CARE has upgraded long term credit rating on the company's bank facilities to B+/Stable, from B/Stable.

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

While Lupin’s (CMP: Rs 1,212; Market Cap: Rs 55,003 crore) quarterly result was not exciting at the top line level, a couple of things stand out. The US market showcased steady market share gains in key drugs – the generic version of ProAir HFA (Albuterol) and Levothyroxine. Further, product rationalisation, along with new launches, helped operating margin improvement. Going forward, other than a strong product pipeline, improving margin trajectory remains on the cards due to product launches in complex generics. Other...

  • PRO Panorama

    Moneycontrol Pro Panorama | Propping up valuations through buybacks no substitute for good performance

    Dec 9, 2022 / 03:28 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Economic churn brings new sectors to forefront, gig jobs replace permanent employment, banks should tap branch network for deposit growth, advance booking is key to any travel plan, and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | When central bankers laugh

    Dec 3, 2022 / 12:13 PM IST

    Cracking jokes during a monetary policy review meeting? Don’t laugh it off. Central bankers in advanced economies are actually walking the laugh

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers